U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06843122) titled 'Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)' on Dec. 30, 2024.
Brief Summary: The goal of this study is to investigate the safety and efficacy of allogenic mesenchymal stem cells isolated from adipose tissue as the treatment for chronic wounds in diabetic foot syndrome in a double-blinded three armed setup.
Study Start Date: March 08
Study Type: INTERVENTIONAL
Condition:
Diabetic Foot Ulcer
Intervention:
BIOLOGICAL: A - Allogenic ADSC cells in fibrin solution - two times administration ADSC/ASC
ADSC/ASC will be administered twice, at two-week intervals - during V0 and V2 vis...